SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-143681
Filing Date
2021-04-30
Accepted
2021-04-30 12:27:00
Documents
7
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d174470ddef14a.htm DEF 14A 1175187
2 GRAPHIC g174470g36i66.jpg GRAPHIC 6692
3 GRAPHIC g174470g41a01.jpg GRAPHIC 69679
4 GRAPHIC g174470g59h58.jpg GRAPHIC 59226
5 GRAPHIC g174470g82r02.jpg GRAPHIC 54597
6 GRAPHIC g174470image001.jpg GRAPHIC 132494
7 GRAPHIC g174470image002.jpg GRAPHIC 135396
  Complete submission text file 0001193125-21-143681.txt   1808211
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 21875510
SIC: 2834 Pharmaceutical Preparations